The National Institutes of Health (NIH) pleased
stem cell watchers today by announcing the names of 10
companies and
research groups that have human
embryonic stem cells federally funded researchers can use.
He predicts that the small but potent
research community of universities and biotech
companies centered in St. Louis and Kansas City will benefit from passage of the amendment — which prevents lawmakers from barring work on
embryonic stem cells while criminalizing cloning with the goal of reproduction — as will patients.